Pharmart SRL
0.1 FTEPharmart reported total assets of €1.51m at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026), with 0.1 full-time equivalent.
The score of Pharmart shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +33 % Total assets +18 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmart's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 04 Aug 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 21 Jun 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
Pharmart's financial analysis
- Solvency95.8%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmart
Pharmart's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0810.249.413
- VAT number
- BE0810249413
- Peppol
- Registered · 0208:0810249413 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Mar 2009
- Registered office
- 1040 Etterbeek
- Size
- Micro · 0.1 FTE
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmart (SRL) has been based in Etterbeek since 2009, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 139,776 € and equity of €1.44m; its revenue is not published. With 0.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 95.8%, above the median of its sector (37.8%).
Companies similar to Pharmart
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Suykerbuyk Retail sale of pharmaceutical products Antwerp · balance sheet €1.51m
- Binche Pharma Retail sale of pharmaceutical products Binche · balance sheet €1.51m
- Pharmacie Hamacker Baillien Retail sale of pharmaceutical products Liège · balance sheet €1.51m
- Apoteek Toelen Retail sale of pharmaceutical products Sint-Pieters-Leeuw · balance sheet €1.51m
- DE Luchthaven Apotheek Retail sale of pharmaceutical products Zaventem · balance sheet €1.50m
- Pharmacies Biot-Gyselinck Retail sale of pharmaceutical products Faimes · balance sheet €1.51m
- Marephar Retail sale of pharmaceutical products Lichtervelde · balance sheet €1.49m
- Lefevre Pharma Retail sale of pharmaceutical products Fleurus · balance sheet €1.53m
Frequently asked questions about Pharmart
What is the revenue of Pharmart?
Pharmart files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmart?
In Belgium, the VAT number is the company number prefixed with BE: BE0810249413 for Pharmart, if the company is VAT-registered. Its company number (CBE) is 0810.249.413.
Where is the registered office of Pharmart?
According to the CBE register, the registered office of Pharmart is in 1040 Etterbeek.
What is the equity of Pharmart?
At the close of the 2025 financial year, the equity of Pharmart amounts to 1,443,042 €, a solvency of 95.8% of total assets.
How many people work at Pharmart?
0.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmart?
The register lists 2 active mandates at Pharmart. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmart
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →